# A Safety and Efficacy Study in Patients With Gastric Cancer

> **NCT00400179** · PHASE3 · COMPLETED · sponsor: **Taiho Oncology, Inc.** · enrollment: 1053 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1/Cisplatin
- **DRUG:** 5-FU/cisplatin

## Key facts

- **NCT ID:** NCT00400179
- **Lead sponsor:** Taiho Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-03
- **Final completion:** 2008-04
- **Target enrollment:** 1053 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400179, "A Safety and Efficacy Study in Patients With Gastric Cancer". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT00400179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*